Episode Details

Filmed at the A5X Conference, Singapore - This interview forms part of a wider series we filmed in collaboration with NUSX, who invited us to Singapore to speak with founders, investors and academics from across the globe about shared challenges, the developing bridge between Europe and Asia, and the lessons we can learn from each other. In this conversation, we sit down with Dr. Babak Parviz, DeepTech inventor and entrepreneur, best known as one of the founders of Google Glass and later as a leader of major innovation initiatives at Amazon. Today he leads NewDays.ai, a startup applying AI to dementia and cognitive care. Dr. Parviz shares what pulled him toward dementia after a career spanning some of the most iconic consumer technology projects of the past two decades - and why he felt this was a problem worth building his next company around. We talk about what NewDays is trying to make better for patients and families, and where AI can genuinely help today in one of healthcare's most human challenges. We explore why Europe and Asia - both dealing with ageing populations at scale - may become the most important testing grounds for new models of dementia care, and what a small company can do in healthcare that a tech giant sometimes cannot. Finally, we discuss whether Europe's more cautious approach to health data and AI regulation slows innovation or can actually help build better, more trusted products - and how AI's growing capabilities could change the way we detect, manage, and even think about dementia over the next five to ten years.